146 related articles for article (PubMed ID: 25870755)
1. Structure of a TLR4-interacting SPA4 peptide.
Awasthi S; Anbanandam A; Rodgers KK
RSC Adv; 2015; 5(35):27431-27438. PubMed ID: 25870755
[TBL] [Abstract][Full Text] [Related]
2. A TLR4-interacting SPA4 peptide inhibits LPS-induced lung inflammation.
Ramani V; Madhusoodhanan R; Kosanke S; Awasthi S
Innate Immun; 2013 Dec; 19(6):596-610. PubMed ID: 23475791
[TBL] [Abstract][Full Text] [Related]
3. A toll-like receptor-4-interacting surfactant protein-A-derived peptide suppresses tumor necrosis factor-α release from mouse JAWS II dendritic cells.
Awasthi S; Brown K; King C; Awasthi V; Bondugula R
J Pharmacol Exp Ther; 2011 Mar; 336(3):672-81. PubMed ID: 21159752
[TBL] [Abstract][Full Text] [Related]
4. TLR4-interacting SPA4 peptide improves host defense and alleviates tissue injury in a mouse model of Pseudomonas aeruginosa lung infection.
Awasthi S; Singh B; Ramani V; Xie J; Kosanke S
PLoS One; 2019; 14(1):e0210979. PubMed ID: 30689633
[TBL] [Abstract][Full Text] [Related]
5. Involvement of endoplasmic reticulum and histone proteins in immunomodulation by TLR4-interacting SPA4 peptide against
Awasthi S; Singh B; Ramani V; Godbole NM; King C
Infect Immun; 2023 Dec; 91(12):e0031123. PubMed ID: 37909750
[TBL] [Abstract][Full Text] [Related]
6. Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide.
Awasthi S; Rahman N; Rui B; Kumar G; Awasthi V; Breshears M; Kosanke S
BMC Pulm Med; 2020 Jun; 20(1):179. PubMed ID: 32576172
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Anti-Inflammatory Activity of TLR4-Interacting SPA4 Peptide.
Awasthi S; Kumar G; Ramani V; Awasthi V; Rodgers KK; Xie J; Beierle J; Kyere-Davies G; Singh B; Rahman N; Chowdhury AA; Chataut N
Immunohorizons; 2021 Aug; 5(8):659-674. PubMed ID: 34429343
[TBL] [Abstract][Full Text] [Related]
8. Effects of SPA4 peptide on lipopolysaccharide-disrupted lung epithelial barrier, injury, and function in a human cell system and mouse model of lung injury.
Chowdhury AA; Godbole NM; Chataut N; Kosanke S; Rodgers K; Awasthi S
Physiol Rep; 2022 Jul; 10(13):e15353. PubMed ID: 35838161
[TBL] [Abstract][Full Text] [Related]
9. Stability and structure-activity relationship of the SPA4 peptide under ambient and stressed conditions of lung injury.
Chowdhury AA; Rodgers K; Godbole NM; Awasthi S
RSC Adv; 2023 Jun; 13(27):18864-18877. PubMed ID: 37350860
[TBL] [Abstract][Full Text] [Related]
10. Solution structure of a synthetic peptide corresponding to a receptor binding region of FSH (hFSH-beta 33-53).
Agris PF; Guenther RH; Sierzputowska-Gracz H; Easter L; Smith W; Hardin CC; Santa-Coloma TA; Crabb JW; Reichert LE
J Protein Chem; 1992 Oct; 11(5):495-507. PubMed ID: 1449599
[TBL] [Abstract][Full Text] [Related]
11. A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells.
Rakhesh M; Cate M; Vijay R; Shrikant A; Shanjana A
Oncoimmunology; 2012 Dec; 1(9):1495-1506. PubMed ID: 23264896
[TBL] [Abstract][Full Text] [Related]
12. Sequential proton NMR resonance assignments, circular dichroism, and structural properties of a 50-residue substrate-binding peptide from DNA polymerase I.
Mullen GP; Vaughn JB; Mildvan AS
Arch Biochem Biophys; 1993 Feb; 301(1):174-83. PubMed ID: 8442659
[TBL] [Abstract][Full Text] [Related]
13. NMR structure of lung surfactant peptide SP-B(11-25).
Kurutz JW; Lee KY
Biochemistry; 2002 Jul; 41(30):9627-36. PubMed ID: 12135384
[TBL] [Abstract][Full Text] [Related]
14. NMR studies of amyloid beta-peptides: proton assignments, secondary structure, and mechanism of an alpha-helix----beta-sheet conversion for a homologous, 28-residue, N-terminal fragment.
Zagorski MG; Barrow CJ
Biochemistry; 1992 Jun; 31(24):5621-31. PubMed ID: 1610809
[TBL] [Abstract][Full Text] [Related]
15. Induced peptide conformations in different antibody complexes: molecular modeling of the three-dimensional structure of peptide-antibody complexes using NMR-derived distance restraints.
Scherf T; Hiller R; Naider F; Levitt M; Anglister J
Biochemistry; 1992 Aug; 31(30):6884-97. PubMed ID: 1379072
[TBL] [Abstract][Full Text] [Related]
16. Conformational behaviour of a synthetic peptide of the C-terminus of villin that interacts with actin: an NMR, CD and stimulated annealing study.
Simenel C; Rose T; Goethals M; Vandekerckhove J; Friederich E; Louvard D; Delepierre M
Int J Pept Protein Res; 1995 Jun; 45(6):574-86. PubMed ID: 7558589
[TBL] [Abstract][Full Text] [Related]
17. The solution structure of photosystem I accessory protein E from the cyanobacterium Nostoc sp. strain PCC 8009.
Mayer KL; Shen G; Bryant DA; Lecomte JT; Falzone CJ
Biochemistry; 1999 Oct; 38(41):13736-46. PubMed ID: 10521281
[TBL] [Abstract][Full Text] [Related]
18. Human nucleotide excision repair protein XPA: 1H NMR and CD solution studies of a synthetic peptide fragment corresponding to the zinc-binding domain (101-141).
Buchko GW; Kennedy MA
J Biomol Struct Dyn; 1997 Jun; 14(6):677-90. PubMed ID: 9195337
[TBL] [Abstract][Full Text] [Related]
19. Structural studies of a synthetic peptide derived from the carboxyl-terminal domain of RNA polymerase II.
Cagas PM; Corden JL
Proteins; 1995 Feb; 21(2):149-60. PubMed ID: 7777490
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein.
Massiah MA; Starich MR; Paschall C; Summers MF; Christensen AM; Sundquist WI
J Mol Biol; 1994 Nov; 244(2):198-223. PubMed ID: 7966331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
